DK175775B1 - - Google Patents

Download PDF

Info

Publication number
DK175775B1
DK175775B1 DK227090A DK227090A DK175775B1 DK 175775 B1 DK175775 B1 DK 175775B1 DK 227090 A DK227090 A DK 227090A DK 227090 A DK227090 A DK 227090A DK 175775 B1 DK175775 B1 DK 175775B1
Authority
DK
Denmark
Prior art keywords
gold
compounds
ointment
formula
agent according
Prior art date
Application number
DK227090A
Other languages
Danish (da)
English (en)
Other versions
DK227090D0 (da
DK227090A (da
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DK227090D0 publication Critical patent/DK227090D0/da
Publication of DK227090A publication Critical patent/DK227090A/da
Application granted granted Critical
Publication of DK175775B1 publication Critical patent/DK175775B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK227090A 1988-03-23 1990-09-20 Organisk guldkompleks til topisk anvendelse DK227090A (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
AUPI738788 1988-03-23
AUPI738788 1988-03-23
AUPI748088 1988-03-28
AUPI748088 1988-03-28
AUPI987888 1988-08-15
AUPI987888 1988-08-15
AUPJ231389 1989-01-18
AUPJ231389 1989-01-18
PCT/AU1989/000118 WO1989009054A1 (en) 1988-03-23 1989-03-22 Topically applied gold organic complex
AU8900118 1989-03-22

Publications (3)

Publication Number Publication Date
DK227090D0 DK227090D0 (da) 1990-09-20
DK227090A DK227090A (da) 1990-09-20
DK175775B1 true DK175775B1 (pt) 2005-02-14

Family

ID=27424233

Family Applications (1)

Application Number Title Priority Date Filing Date
DK227090A DK227090A (da) 1988-03-23 1990-09-20 Organisk guldkompleks til topisk anvendelse

Country Status (15)

Country Link
EP (1) EP0417105B1 (pt)
JP (1) JPH0725681B2 (pt)
AT (1) ATE108655T1 (pt)
AU (1) AU616755B2 (pt)
CA (1) CA1337928C (pt)
CH (1) CH676325A5 (pt)
DE (1) DE68916958T2 (pt)
DK (1) DK227090A (pt)
ES (1) ES2021898A6 (pt)
GR (1) GR1000698B (pt)
IE (1) IE61381B1 (pt)
MX (1) MX9203739A (pt)
NZ (1) NZ228367A (pt)
PT (1) PT90085B (pt)
WO (1) WO1989009054A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683446B2 (ja) * 1990-09-28 1997-11-26 住友電気工業株式会社 ハーネス用電線導体
AUPO347396A0 (en) * 1996-11-04 1996-12-05 Medical Innovations Limited Synergistic gold-containing compositions
AU747169B2 (en) * 1996-11-04 2002-05-09 Psiron Limited Synergistic gold-containing compositions
AU2001276186B2 (en) * 2000-08-03 2006-08-17 Psiron Limited A method of preparing a pharmaceutical composition
AUPQ916700A0 (en) * 2000-08-03 2000-08-24 Psiron Limited A method of preparing a pharmaceutical composition
ES2261659T3 (es) 2001-04-23 2006-11-16 Nucryst Pharmaceuticals Corp. Un medicamento o una preparacion que contiene un metal tal como plata, oro, platino o paladio como un agente antimicrobiano y su uso para el tratamiento de estados inflamatorios de la piel.
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757672A (fr) * 1969-10-28 1971-04-19 Smith Kline French Lab Complexes d'auro-trialcoylphosphine de 1-beta-D-glucopyranosides
US4096250A (en) * 1977-02-25 1978-06-20 Smithkline Corporation Tri-substituted phosphinegold(I) 1-thio-β-D-glucopyranosides
US4131732A (en) * 1977-04-21 1978-12-26 Smithkline Corporation Method for preparing auranofin
US4125710A (en) * 1977-06-30 1978-11-14 Smithkline Corporation Method for preparing auranofin
US4122254A (en) * 1977-06-30 1978-10-24 Smithkline Corporation Process for preparing auranofin
US4330530A (en) * 1980-12-22 1982-05-18 The Procter & Gamble Company Anti-arthritic compositions and method using gold salts and organophosphonates
HUT37342A (en) * 1983-10-17 1985-12-28 Caola Kozmetikai Process for production of preparatives for medical cosmetics
US4657763A (en) * 1985-09-03 1987-04-14 Michael Ebert Combined chrysotherapeutic agents for autoimmune diseases
JPH01228907A (ja) * 1988-03-09 1989-09-12 Kosuke Harada 外用クリーム

Also Published As

Publication number Publication date
EP0417105B1 (en) 1994-07-20
GR1000698B (el) 1992-10-08
IE890896L (en) 1989-09-23
AU616755B2 (en) 1991-11-07
CA1337928C (en) 1996-01-16
PT90085B (pt) 1994-06-30
DE68916958T2 (de) 1995-01-19
WO1989009054A1 (en) 1989-10-05
IE61381B1 (en) 1994-11-02
EP0417105A1 (en) 1991-03-20
PT90085A (pt) 1989-11-10
GR890100183A (en) 1990-01-19
MX9203739A (es) 1992-07-31
CH676325A5 (pt) 1991-01-15
EP0417105A4 (en) 1992-08-19
JPH03505572A (ja) 1991-12-05
ES2021898A6 (es) 1991-11-16
DK227090D0 (da) 1990-09-20
JPH0725681B2 (ja) 1995-03-22
NZ228367A (en) 1992-02-25
DE68916958D1 (de) 1994-08-25
ATE108655T1 (de) 1994-08-15
DK227090A (da) 1990-09-20
AU3435189A (en) 1989-10-16

Similar Documents

Publication Publication Date Title
JP3706792B2 (ja) 局所用亜鉛組成物および使用方法
KR100866025B1 (ko) 통증 치료를 위한 비스포스포네이트의 용도
JP2005008534A (ja) 抗癌剤及び癌の治療方法
JP5416327B2 (ja) タキサンにより惹起される神経毒性を予防又は軽減するための薬剤
DK175775B1 (pt)
KR20180103194A (ko) 암 치료를 위한 유기 비소 화합물 및 방법
WO1993023054A1 (en) Polyphosphorylated organic compounds: compositions useful in protecting biological tissues
US5527779A (en) Topically applied gold organic complex
EP0001871B1 (en) An erythromycin compound, a process for preparing the compound and compositions containing the compound useful in the treatment of acne
US6436913B1 (en) Use of estramustine phosphate in the treatment of bone metastasis
CN111514290B (zh) 一种葫芦素组合物及其用途
NZ205587A (en) Composition comprising undecylenic acid for treating herpes simplex i
KR0128663B1 (ko) 국소 적용된 금유기 착화합물
KR101088762B1 (ko) 에이코사펜타에노산을 포함하는 탈모 방지 및 발모 촉진용 나노하이브리드 복합체 및 발모 촉진용 조성물
AU2015295817B2 (en) Composition containing apomorphine and a divalent metal cation
US20040014729A1 (en) Use of estramustine phosphate in the treatment of bone metastasis

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PBP Patent lapsed

Country of ref document: DK